Public-registry site landscape for NCT05035082, a Diabetes Mellitus, Type 2 study sponsored by Novo Nordisk A/S. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05035082 (registry record) |
| Sponsor | Novo Nordisk A/S |
| Condition(s) | Diabetes Mellitus, Type 2 |
| Phase | PHASE4 |
| Listed sites | 25 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT05035082 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →